Sara Imboden

Sara Imboden has a diverse work experience, starting in 2015 as a Project Team Member at RR Donnelley. Sara then moved on to teaching assistant roles at ETH Zürich in 2018 and 2019. In 2019, Sara worked as a Research Intern with the Research in Orthopedic Computer Science (ROCS) Group at Universitätsklinik Balgrist. From 2020 to 2022, they served as a Graduate Research Assistant at UCLA Henry Samueli School of Engineering and Applied Science, where they maintained and differentiated human/mammalian cell lines and investigated the effects of novel compounds on proliferation and viability. Sara then became a Research & Development Engineer I at UCLA from 2022 to 2023. Currently, Sara is a Research Associate II at A2 Biotherapeutics, Inc.

Sara Imboden completed their education at ETH Zürich, where they earned a Bachelor of Science (BS) degree in Health Sciences and Technology from 2015 to 2018. Sara then pursued a Master of Science (MS) degree in the same field from ETH Zürich from 2018 to 2021. There is no information available about their education prior to ETH Zürich, but it is worth noting that they had some affiliation with the UCLA Henry Samueli School of Engineering and Applied Science, although details about their degree and field of study are unspecified.